Immunovant (IMVT) Operating Expenses (2018 - 2026)
Immunovant (IMVT) reported Operating Expenses of $160.32 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 26.0% from $127.22 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Operating Expenses (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunovant's Operating Expenses came in at $566 million, up 20.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $532.9 million, up 21.6% from FY2025.
- Operating Expenses has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 37.6% (FY2021 to FY2026).
- By fiscal year, Operating Expenses came in at $438.15 million in FY2025 (+55.0%), $282.71 million in FY2024 (+29.5%), $218.28 million in FY2023 (+39.9%) and $156.03 million in FY2022 (+44.3%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Operating Expenses in data going back to fiscal Q3 2019.
- Year over year, Operating Expenses has now increased in each of the last ten quarters, with growth averaging 41.1% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was fiscal Q1 2024 (growth of 94.4%); the low point was fiscal Q3 2024 (a decline of 3.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $159.55 million (Q4 2026), $114.36 million (Q3 2026) and $131.76 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Immunovant | 6.91 Bn | 6.91 Bn | - | 160.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 160.32 Mn |
| Mar 31, 2026 | 159.55 Mn |
| Dec 31, 2025 | 114.36 Mn |
| Sep 30, 2025 | 131.76 Mn |
| Jun 30, 2025 | 127.22 Mn |
| Mar 31, 2025 | 113.83 Mn |
| Dec 31, 2024 | 114.30 Mn |
| Sep 30, 2024 | 115.74 Mn |
| Jun 30, 2024 | 94.28 Mn |
| Mar 31, 2024 | 80.88 Mn |
| Dec 31, 2023 | 61.55 Mn |
| Sep 30, 2023 | 61.80 Mn |
| Jun 30, 2023 | 78.48 Mn |
| Mar 31, 2023 | 64.26 Mn |
| Dec 31, 2022 | 64.03 Mn |
| Sep 30, 2022 | 49.61 Mn |
| Jun 30, 2022 | 40.38 Mn |
| Mar 31, 2022 | 47.23 Mn |
| Dec 31, 2021 | 41.27 Mn |
| Sep 30, 2021 | 37.65 Mn |
API Access
Immunovant Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();